ECONSALUT
Critical comments on health economics and policy
27 d’octubre 2018
The "secret sauce" of Kaiser Permanente
›
Financing and Payment Strategies to Support High-Quality Care for People with Serious Illness: Proceedings of a Workshop A recent report...
26 d’octubre 2018
The media and the Theranos incredible deception
›
On Theranos failure, highly recommended for journalists. From CBSNEWS, a basic piece to understand the power of the media in creating and ...
20 d’octubre 2018
The biggest financial heist in history
›
BILLION DOLLAR WHALE The Man Who Fooled Wall Street, Hollywood, and the World In 2009, with the dust yet to settle on the financial cris...
18 d’octubre 2018
Forecasting global life expectancy and morbidity
›
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternati...
11 d’octubre 2018
Genome sequencing, what's it worth?
›
Evaluating the Outcomes Associated with Genomic Sequencing: A Roadmap for Future Research The health economic evidence base for WES -whole...
06 d’octubre 2018
Geisinger (it is not any fiord)
›
A suggestion for weekend reading: excellent interview by Eric Topol with the Geisinger Health System CEO, in Medscape . Regarding genetics...
03 d’octubre 2018
As time goes by
›
The order of time I've just finished the book I started this summer: The order of time . It's quite difficult to enter in physicis...
27 de setembre 2018
Insuring biomarkers coverage
›
From the Past to the Present:Insurer Coverage Frameworks for Next-Generation Tumor Sequencing Technology is one step ahead regulation and ...
24 de setembre 2018
Healthcare services governance
›
The Firm Divided Manager-Shareholder Conflict and the Fight for Control of the Modern Corporation There is a unique feature of health ser...
21 de setembre 2018
Economics of ownership in healthcare
›
Private Provision of Publicly Funded Health Care: The Economics of Ownership You'll find an interesting review of public private provi...
18 de setembre 2018
Are we paying too much for pharmaceutical innovation?
›
Economics of the Pharmaceutical Industry The question of whether innovation is too high or too low is a first-order—perhaps the first- ord...
14 de setembre 2018
Lamarck returns
›
Lamarck's Revenge: How Epigenetics Is Revolutionizing Our Understanding of Evolution's Past and Present I've just started to r...
13 de setembre 2018
Commercial determinants of health
›
Systems Thinking as a Framework for Analyzing Commercial Determinants of Health Unhealthy commodity industries (UCIs) are defined as...
07 de setembre 2018
Reviewing health systems
›
Spain Health system review The series Health systems in transition by WHO is a helful source to understand the current state of healthcare...
‹
›
Inici
Visualitza la versió per a web